| Patents for A61P 31 - Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics (179,784) |
|---|
| 03/31/2004 | CN1143676C Application of sodium taurocholate as synergist for antituberculosis antibiotic |
| 03/31/2004 | CN1143618C Precise efficiency assay methods for active agents including chemotherapeutic agents |
| 03/30/2004 | US6713616 Detecting binding |
| 03/30/2004 | US6713507 Ether compounds and compositions for cholesterol management and related uses |
| 03/30/2004 | US6713504 Antifungal molecule 2-(3,4-dimethyl-2,5-dihydro-1H-pyrrol-2-yl)-1-methylethyl pentanoate |
| 03/30/2004 | US6713502 Anti-infectives |
| 03/30/2004 | US6713491 For use as medicine for antagonising the effects of excitatory amino acids upon the nmda receptor complex |
| 03/30/2004 | US6713490 6-(2-(4-(3-fluorophenyl)-4-hydroxy-1-piperidinyl)-1-hydroxy -ethyl)-3,4-dihydro-2(1h)-quinolinone; reduced inhibitory activity at herg (human ether-a-go-go related gene) potassium channel |
| 03/30/2004 | US6713487 Heterocyclic amine derivatives; for treating an inflammatory or immune disease, a cardiovascular disease, or a neurodegenerative condition |
| 03/30/2004 | US6713456 Nucleozymes |
| 03/30/2004 | US6713455 6-O-carbamate-11,12-lacto-ketolide antimicrobials |
| 03/30/2004 | US6713446 Boronic acid compounds obtained by lyophilization of an aqueous mixture of the boronic acid compound and a sugar having at least two hydroxyl groups; shelf life |
| 03/30/2004 | US6713301 Artificial T helper cell epitopes as immune stimulators for synthetic peptide immunogens |
| 03/30/2004 | US6713252 Using adsorption carrier |
| 03/30/2004 | US6713073 Whole body spray |
| 03/30/2004 | US6713070 Viral particles which are released after the infection with the human cytomegalovirus, and the use of said particles as a vaccine |
| 03/30/2004 | US6713068 Live recombined vaccines injected with adjuvant |
| 03/30/2004 | US6713064 Immune enhancing agent for treating HIV infected humans |
| 03/30/2004 | US6713056 Combined preparation for the treatment of neoplasic diseases or of infectious diseases |
| 03/30/2004 | CA2318359C Polymeric compounds and methods of formulating same |
| 03/30/2004 | CA2235471C Dna encoding a plasminogen activating protein |
| 03/30/2004 | CA2152907C Antiviral topical pharmaceutical compositions |
| 03/30/2004 | CA2130755C Intermediates useful in the preparation of purine nucleoside analogues |
| 03/30/2004 | CA2129132C Antiviral agent |
| 03/25/2004 | WO2004025416A2 Bioinformatic method for identifying surface-anchored proteins from gram-positive bacteria and proteins obtained thereby |
| 03/25/2004 | WO2004025256A2 Viral deconstruction through capsid assembly in vitro |
| 03/25/2004 | WO2004024925A2 Collectin-complement activating protein chimeras |
| 03/25/2004 | WO2004024919A1 Non-sequence complementary antiviral oligonucleotides |
| 03/25/2004 | WO2004024914A1 2’,5’-oligoadenylate phosphodiesterase |
| 03/25/2004 | WO2004024909A2 Recombinant colstridium neurotoxin fragments |
| 03/25/2004 | WO2004024904A2 Infectious hepacivirus pseudo-particles containing functional e1, e2 envelope proteins |
| 03/25/2004 | WO2004024900A1 USE OF DENDRITIC CELLS (DCs) EXPRESSING INTERLEUKIN 12 (IL-12) |
| 03/25/2004 | WO2004024889A2 Production of bispecific molecules using polyethylene glycol linkers |
| 03/25/2004 | WO2004024743A1 Crystal of 2-amino-6-(4-methoxyphenylthio)-9-[2-(phosphonomethoxy)ethyl]purine bis(2,2,2-trifluoroethyl) ester |
| 03/25/2004 | WO2004024717A1 Isoquinoline derivatives having kinasae inhibitory activity and drugs containing the same |
| 03/25/2004 | WO2004024713A1 Piperidine quinolyl propyl derivatives and use thereof as antimicrobial agents |
| 03/25/2004 | WO2004024712A1 Piperidine quinolyl propyl derivatives, preparation method and intermediates and compositions containing same |
| 03/25/2004 | WO2004024697A1 Amine compounds and use thereof |
| 03/25/2004 | WO2004024693A1 Heterocyclic compound having hiv integrase inhibitory activity |
| 03/25/2004 | WO2004024685A1 Novel dipeptide compound and medical use tehreof |
| 03/25/2004 | WO2004024676A1 Compounds for modulating the glycolosis enzyme complex and/or transaminase complex |
| 03/25/2004 | WO2004024673A1 Amino-propanol derivatives |
| 03/25/2004 | WO2004024173A2 A mechanism for hiv-1 entry into host cells and peptides inhibiting this mechanism |
| 03/25/2004 | WO2004024147A1 4-(3,5-dicyanophenoxy) pyrazole derivatives for use as transcriptase modulators in the treatment of i.a. hiv |
| 03/25/2004 | WO2004024129A1 Induced remission therapy |
| 03/25/2004 | WO2004024095A2 ß-L-2'-DEOXYNUCLEOSIDES FOR THE TREATMENT OF RESISTANT HBV STRAINS AND COMBINATION THERAPIES |
| 03/25/2004 | WO2004024088A2 Design of chemokine analogs for the treatment of human diseases |
| 03/25/2004 | WO2004024078A2 Dihydroxypyridopyrazine-1,6-dione compounds useful as hiv integrase inhibitors |
| 03/25/2004 | WO2004013138A3 Imidazo`1,2-a!pyridines |
| 03/25/2004 | WO2003105890A3 Vaccine comprising mixtures of multivalent meningococcal outer membrane vesciles |
| 03/25/2004 | WO2003103822A3 Stealth lipid nanocapsules, methods for the preparation thereof and use thereof as a carrier for active principle(s) |
| 03/25/2004 | WO2003095665A3 Pmea and pmpa cyclic producing synthesis |
| 03/25/2004 | WO2003092624A3 Use of heat shock proteins to enhance efficacy of antibody therapeutics |
| 03/25/2004 | WO2003092610A3 Methods of using cytokine antagonists to treat hiv infection and aids |
| 03/25/2004 | WO2003091401A3 Multi plasmid system for the production of influenza virus |
| 03/25/2004 | WO2003090726A3 Chewable soft capsule |
| 03/25/2004 | WO2003086326A3 G-type peptides to ameliorate atherosclerosis |
| 03/25/2004 | WO2003084941A3 Hydroxamic acid derivatives |
| 03/25/2004 | WO2003082908A3 Use of the p17 protein of hiv in isolated form for the preparation of a medicament for administration to hiv seropositive patients, as well as pharmaceutical compositions comprising said protein |
| 03/25/2004 | WO2003082260A3 Tuberculosis treatment using pleuromutilin derivatives |
| 03/25/2004 | WO2003077862A3 Potent, simplified derivatives of immunosuppressive agents |
| 03/25/2004 | WO2003076591A3 Compositions and methods for generating an immune response |
| 03/25/2004 | WO2003075654A3 Treatment of surfaces populated by bacteria with a lucilia sericata extract |
| 03/25/2004 | WO2003057823A3 Epitope synchronization in antigen presenting cells |
| 03/25/2004 | WO2003043613A3 Use of glycosides of mono- and diacylglycerol as anti-inflammatory agents |
| 03/25/2004 | WO2003037860A3 Purine analogs having hsp90-inhibiting activity |
| 03/25/2004 | WO2003037361A3 Use of tissue factor agonist or tissue factor antagonist for treatment of conditions related to apoptosis |
| 03/25/2004 | WO2003014731B1 The natural ligand for orphan g protein coupled receptor gpr86 and methods of use |
| 03/25/2004 | WO2003012122A8 Crystallized structure of type iv collagen nc1 domain hexamer |
| 03/25/2004 | WO2003011008A3 Therapeutic delivery compositions and methods of use thereof |
| 03/25/2004 | WO2003006501A3 G-csf conjugates |
| 03/25/2004 | WO2002102829A3 Cross-reactive monoclonal and polyclonal antibodies which recognize surface proteins from coagulase-negative staphylococci and staphylococcus aureus |
| 03/25/2004 | WO2002089832A3 Pharmaceutical compositions for preventing or treating th1 and th2 cell related diseases by modulating the th1/th2 ratio. |
| 03/25/2004 | WO2002085093A3 Replikin peptides and uses thereof |
| 03/25/2004 | WO2002083859A8 Surface proteins of streptococcus pyogenes |
| 03/25/2004 | WO2002063006A3 Receptors and membrane-associated proteins |
| 03/25/2004 | WO2002002095B1 Compositions for treating bacterial infections containing oxazolidinone compound, sulbactam and an ampicillin |
| 03/25/2004 | US20040059281 Delivery system and method of treating or preventing otitis media |
| 03/25/2004 | US20040059130 Benz(f)indole compounds useful for Inflammatory Diseases |
| 03/25/2004 | US20040059120 Such as (5R)-3-(3-fluoro-4-(2-oxo-1,3-oxazolan-3-yl)phenyl)-5-hydroxymethyl-1,3 -oxazolan-2-one |
| 03/25/2004 | US20040059115 Such as ((benzylsulfonylamino)methyl)-phosphonic acid mono-(4-nitrophenyl)ester sodium salt; for treating bacterial antibiotic resistance |
| 03/25/2004 | US20040059113 Such as 3-(1-(2-hydroxyethyl)-1H-indol-3-yl)-4-(1-(3-pyridinyl)-1H-indol-3-yl)-1H -pyrrole-2,5-dione |
| 03/25/2004 | US20040059104 Nucleotide mimics and their prodrugs |
| 03/25/2004 | US20040059087 Peptide nucleic acids |
| 03/25/2004 | US20040059017 Method for producing a partial or complete active ingredient coating on and in implants and onplants |
| 03/25/2004 | US20040058999 Aids therapy; using xanaldial, xenalamine, xenalic acid |
| 03/25/2004 | US20040058988 Fatty acid synthase inhibitors |
| 03/25/2004 | US20040058983 Plan-derived and synthetic phenolic compounds and plant extracts, effective in the treatment and prevention of chlamydial infections |
| 03/25/2004 | US20040058981 Administering free radical generators such as artemisinim, arteflene |
| 03/25/2004 | US20040058980 Useful aroyl pyrrole heteroaryl methanones and methanols |
| 03/25/2004 | US20040058974 Administering posaconazole by mouth |
| 03/25/2004 | US20040058965 Alkanoic acid derivatives process for their production and use thereof |
| 03/25/2004 | US20040058964 Antiinflammatory agents; antiarthritic agents; antihistamines; sepsis shock; antidiabetic agents; bone disorders |
| 03/25/2004 | US20040058961 Antiallergens; antihistamines; autoimmune diseases; anticholesterol agents; cardiovascular diseases |
| 03/25/2004 | US20040058952 Urease inhibitors |
| 03/25/2004 | US20040058941 Pyrimidinone derivatives and their use in the treatment of atherosclerosis |
| 03/25/2004 | US20040058937 Heterocyclic mutilin esters and their use as antibacterials |
| 03/25/2004 | US20040058932 Novel piperazine derivatives |
| 03/25/2004 | US20040058924 Use of amidoamines to treat or prevent acanthamoeba and fungal infections |
| 03/25/2004 | US20040058923 Morpholin-acetamide derivatives for the treatment of inflammatory diseases |